LUK Corp. · LUK Insight · Regulatory Signal · 2026
means for Korean SPF
For two decades, the hardest part of bringing a Korean sunscreen into the US wasn't demand — it was the filter list. On June 9, 2026, the FDA approved bemotrizinol, the first new sunscreen active in over 20 years. The barrier just dropped. Here's exactly what changed, and what it means if you make or buy SPF.
01The first new UV filter in 20 years
On June 9, 2026, the FDA added bemotrizinol to its list of permitted over-the-counter sunscreen active ingredients — the first addition to the OTC sunscreen monograph since the late 1990s. The US went from 16 approved filters to 17.
The numbers that matter
A few details that matter for formulation: bemotrizinol is permitted up to 6%, approved for adults and children 6 months and older, and manufacturers may begin using it from August 9, 2026. It's highly photostable, offers strong UVA coverage, and can be combined with zinc oxide for broad-spectrum protection with less white cast.
02Why this was the bottleneck
Here's the part many brands underestimate: in the US, sunscreen is not a cosmetic — it's an OTC drug. That single fact reshapes everything.
A cosmetic everywhere, a drug in the US
The reason a great-selling formula still couldn't enter
- OTC drug status — sunscreen is regulated as medicine, not cosmetics
- FDA-approved filters only — you cannot use a filter that isn't on the list
- "Drug Facts" labeling — active %, uses, warnings, directions, all required
Bemotrizinol has been used in Europe (since 2000), Australia and parts of Asia for years. But Korean sunscreens built on that filter — or on filter combinations the US hadn't approved — simply could not enter the American market. The wall was never demand. It was the monograph.
03Case study: redesigning for the US
You can already see how brands solved this. Beauty of Joseon's hero SPF, Relief Sun: Rice + Probiotics, uses a filter system that isn't approved as-is in the US. So for the American market, the brand didn't just relabel — it reformulated around FDA-permitted filters (avobenzone and others) and launched a US-specific SKU.
Same brand, same positioning — but a separate formula and a separate registration path for the US. That's the cost of the OTC-drug gate, and it's exactly the work bemotrizinol now makes easier for the next wave of products.
A product that sells well
isn't the same as a product you can sell.
04"Sells well" vs. "can be sold"
Korean sunscreen is one of the few categories where US consumer demand is already proven. The constraint was never the market — it was clearing three gates at once.
Demand is given. Clearance isn't.
- Proven demand — Korean SPF is a category US shoppers actively seek
- Texture & finish — the no-white-cast reputation already exists
- Ingredients — only FDA-approved filters
- SPF labeling — US testing & claim rules
- FDA / OTC — drug-facts compliance, MoCRA registration
With bemotrizinol approved, the ingredient gate just got wider — more Korean SPF formulas can now be made US-compliant without starting the chemistry from zero.
05What actually changes now
It's a real opening — but not a free pass. Two things are true at once:
What opened, and what didn't
- Opened: a modern, photostable UVA filter is now US-legal — more formulas qualify
- Still required: US-spec design, FDA SPF testing, Drug Facts, MoCRA registration
- Timeline: manufacturers may use bemotrizinol from August 9, 2026 — plan around it
The brands that win this window won't be the ones that simply ship their existing SKU. They'll be the ones that designed for the US from day one — and were ready the moment the filter cleared.
06Three insights for OEM partners
If a US sunscreen launch is on your roadmap, the approval changes your options — but not your obligations. Three operating principles:
Design US-spec from day one
Treat SPF as an OTC drug from the brief. FDA-permitted filter set, Drug Facts label, US SPF testing, and MoCRA registration are not afterthoughts — they're the spec.
Use the wider toolbox
Bemotrizinol adds a photostable UVA filter that combines with zinc oxide for less white cast. It widens what a US-compliant Korean SPF can feel like — usable from August 9, 2026.
Move while the window is open
Demand is proven; the constraint was always regulatory. The brands that get compliant formulation + testing right first take the shelf — the rest wait in the queue.
How this fits the framework
This is the regulatory dimension of the same pattern the LUK Insight series tracks: the gap between a product that sells and a product that's allowed to sell.
07OEM FAQ
Does the bemotrizinol approval mean our existing Korean sunscreen can ship to the US now?
Not automatically. The approval widens the filter options, but US sunscreen is still an OTC drug: it must use only FDA-permitted filters, carry a compliant Drug Facts label, pass US SPF/broad-spectrum testing, and be MoCRA-registered. Also note manufacturers may only use bemotrizinol from August 9, 2026. LUK Corp. assesses your current formula and maps the gap to US-ready.
Can LUK Corp. reformulate our SPF specifically for the US market?
Yes — that is a core capability. We redesign around the FDA-permitted filter set (now including bemotrizinol where suitable), target the SPF/PA performance you need, and prepare the US label and testing package. The result is a US-specific SKU, the same approach brands like Beauty of Joseon used for their US line.
What testing and documentation does a US sunscreen require?
Typically: FDA SPF and broad-spectrum testing, water-resistance testing if claimed, stability and PET, a complete Drug Facts panel (active %, uses, warnings, directions), and MoCRA facility/product registration. LUK Corp. coordinates the testing labs and compiles the documentation as part of the development package.
Is bemotrizinol better than the filters we use now?
It's a strong addition, not a universal replacement. Bemotrizinol is highly photostable, gives robust UVA protection, and pairs with zinc oxide to reduce white cast — useful for deeper skin tones and daily-wear textures. Whether it fits your product depends on target SPF, finish, and cost; LUK Corp. advises on the optimal filter system per SKU.
What are the standard MOQ, lead time, and payment terms?
MOQ: 5,000 units per SKU (pilot ~2,000 possible). Lead time: roughly 2–3 months for a first order, plus US SPF testing and registration time. Payment: 50% deposit / 50% balance before shipping. LUK Corp. provides a combined reformulation + testing + labeling + registration schedule in the proposal.
How does an OEM project start with LUK Corp.?
Initial briefing is free. Share three things: (1) target market(s) and SPF/finish goals, (2) brand vocabulary and visual direction, and (3) target unit cost or retail range. Contact via the link below or email ceo@luk.co.kr, and LUK Corp. drafts a formulation + testing + labeling + pricing proposal. A paid sample round follows before MOQ commitment.
Let's make your SPF US-ready
FDA-permitted filters, US SPF testing, Drug Facts labeling, and MoCRA registration — coordinated as one pipeline. The door is open; the brands that designed for it move first.
Contact LUK Corp.LUK Corp. · Manufactured in Korea · OEM/ODM Partner · ceo@luk.co.kr · @lukcos_2015